Financials Bactiguard Holding AB

Equities

BACTI B

SE0005878741

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 05:01:19 2024-04-29 am EDT 5-day change 1st Jan Change
69.6 SEK +1.16% Intraday chart for Bactiguard Holding AB +0.87% +12.62%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 3,869 2,166 2,439 - -
Enterprise Value (EV) 1 3,869 2,276 2,621 2,618 2,576
P/E ratio -73.1 x -15.6 x -30.6 x -84.9 x 58.3 x
Yield - - - - -
Capitalization / Revenue - 9.7 x 11.5 x 10.3 x 8.05 x
EV / Revenue - 10.2 x 12.4 x 11.1 x 8.5 x
EV / EBITDA - -29.9 x -165 x 76.5 x 31.4 x
EV / FCF - - -32.8 x -374 x 80.5 x
FCF Yield - - -3.05% -0.27% 1.24%
Price to Book - - 8.8 x 9.81 x 8.39 x
Nbr of stocks (in thousands) 35,044 35,044 35,044 - -
Reference price 2 110.4 61.80 68.80 68.80 68.80
Announcement Date 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 223.2 211.8 236.8 303
EBITDA 1 - -76.07 -15.93 34.22 82
EBIT 1 - -131.9 -65.06 -13.98 57
Operating Margin - -59.12% -30.73% -5.9% 18.81%
Earnings before Tax (EBT) 1 - -147.2 -83.06 -29.98 44
Net income 1 -52.88 -138.4 -78.98 -28.22 41
Net margin - -62.01% -37.3% -11.92% 13.53%
EPS 2 -1.510 -3.950 -2.250 -0.8100 1.180
Free Cash Flow 1 - - -80 -7 32
FCF margin - - -37.78% -2.96% 10.56%
FCF Conversion (EBITDA) - - - - 39.02%
FCF Conversion (Net income) - - - - 78.05%
Dividend per Share 2 - - - - -
Announcement Date 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 58.79 53 53 55
EBITDA 1 -1.501 -6 -3 1
EBIT 1 -12.87 -18 -16 -11
Operating Margin -21.89% -33.96% -30.19% -20%
Earnings before Tax (EBT) 1 -12.2 -22 -20 -16
Net income 1 -9.901 -21 -19 -15
Net margin -16.84% -39.62% -35.85% -27.27%
EPS 2 -0.2800 -0.6100 -0.5400 -0.4300
Dividend per Share - - - -
Announcement Date 4/25/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 110 182 179 137
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - -1.445 x -11.43 x 5.229 x 1.671 x
Free Cash Flow 1 - - -80 -7 32
ROE (net income / shareholders' equity) - -32.6% -25.2% -10.9% 15.6%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - - 7.820 7.010 8.200
Cash Flow per Share - - - - -
Capex 1 - 7.19 7 10 12
Capex / Sales - 3.22% 3.31% 4.22% 3.96%
Announcement Date 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. BACTI B Stock
  4. Financials Bactiguard Holding AB